Biotech news continually updated from thousands of sources around the net.
3 hrs ago | Reuters
U.S. regulators announced new guidelines on Wednesday to phase out the use of antibiotics as a growth enhancer in livestock, in an effort to stem a surge in human resistance to these drugs.
Are you smarter than a 7th grade civics student?
Should polygamy be legal among consenting adults?
4 hrs ago | PhysOrg Weblog
The Food and Drug Administration says it has approved the first generic versions of the blockbuster antidepressant drug Cymbalta, offering lower-cost access to one of the most widely prescribed treatments for depression, anxiety and other disorders.
9 hrs ago | Reuters
CytRx Corp said its experimental cancer treatment improved survival rates in untreated soft tissue sarcoma patients without the disease progressing, compared with standard chemotherapy alone, sending the company's shares up as much as 83 percent.
13 hrs ago | Lexington Herald-Leader
A pair of traders confer on the floor of the New York Stock Exchange Tuesday, Dec. 3, 2013.
17 hrs ago | Barron's
We are raising 2017 total sales and EPS to $13B and $16.00 . The largest change to our model is an increase in Revlimid sales to $7.6B due to lengthening of treatment duration and increasing penetration in the first-line setting following positive MM-020 presented over the weekend at the ASH Meeting.
GlaxoSmithKline is to invest another 200 million pounds on advanced manufacturing in Britain, the company said on Wednesday, underlining the draw of a tax break designed to encourage research and development.
AbbVie Inc's all-oral hepatitis C therapy cured 96 percent of difficult-to-treat patients in a late-stage clinical trial after 12 weeks, keeping the company well placed in a highly competitive race to deliver new treatments for the serious liver disease.
Tomorrow, it happens again — with wrenching familiarity — at Eli Lilly and Co. Another top-selling Lilly drug loses U.S. patent protection, opening the door to cheaper-priced generics that will immediately start grabbing prescription share worth billions of dollars in annual sales.
The European Commission has fined pharmaceuticals giants Johnson & Johnson and Novartis a combined $22 million for colluding to delay the entrance of a cheap generic form of a pain killer to the Dutch market.
Scientists at the company started a long history of innovation in 1978 by successfully expressing a human gene in bacteria that allowed them to produce human insulin.
The U.S. Supreme Court on Monday left intact a $142 million jury verdict against Pfizer Inc. over the company's marketing of the epilepsy drug Neurontin.
Specialty drugmaker United Therapeutics Corp. said Monday that it received a subpoena from federal regulators looking into the company's marketing of three drugs used to treat a form of hypertension.
U.S. Centers for Disease Control and Prevention meningitis expert Thomas Clark says that shortly after vaccinations began at noon Monday, scores of students were in line and some had received the dose.
Medical devices firm DePuy is to create 38 new jobs as part of an expansion of its facility in Ringaskiddy, Co Cork.
A newspaper investigation reveals that Americans overpay for a vision treatment when a cheaper version is available at 1/40th the cost.
Applications are being accepted for $8 million in grants designed to improve the delivery of mental health and substance abuse services in Massachusetts.